Titomic Raises A$50M at A$0.25 per Share, Discounted to Market Price
Titomic Limited has successfully raised A$50 million through a strategic share placement, aiming to fuel its growth in industrial-scale metal additive manufacturing. The capital raise underscores investor confidence as the company prepares to expand its global footprint.
- A$50 million raised via non-underwritten placement at A$0.25 per share
- Placement shares issued at a 3.8% discount to last closing price
- Additional A$0.35 million conditional placement to directors pending shareholder approval
- Proceeds earmarked to accelerate expansion and growth initiatives
- Settlement expected by 30 July 2025 with trading from 31 July 2025
Capital Raise Details
Titomic Limited (ASX, TTT), a leader in industrial-scale metal additive manufacturing, announced a successful capital raise of approximately A$50 million through a non-underwritten placement of 201.4 million new shares priced at A$0.25 each. This price represents a modest 3.8% discount to the company’s last closing price on 23 July 2025, reflecting a strategic move to attract institutional and sophisticated investors.
In addition to the main placement, the company has proposed a conditional placement of A$0.35 million to its directors, subject to shareholder approval at the upcoming Annual General Meeting. This gesture signals strong alignment and confidence from the board in the company’s growth trajectory.
Strategic Implications
CEO and Managing Director Jim Simpson expressed gratitude to investors, highlighting the raise as a robust endorsement of Titomic’s growth strategy. The funds are intended to accelerate expansion efforts, enabling the company to sustain momentum across key initiatives and reinforce its presence in global markets, particularly in aerospace, defense, and industrial sectors.
Titomic’s patented kinetic fusion cold spray technology underpins its competitive advantage, offering innovative solutions in metal additive manufacturing, coatings, and repairs. The capital injection is expected to support scaling operations, R&D, and market penetration in the US, Australia, and Europe.
Market and Shareholder Considerations
The placement shares will be issued within existing placement capacity, with settlement anticipated by 30 July 2025 and trading commencing the following day. While the discount to recent trading prices is modest, investors will be watching closely for dilution effects and the company’s execution of its expansion plans.
Joint Lead Managers Barrenjoey Markets and Bell Potter Securities, alongside co-managers Peloton Capital and Gleneagle Securities, facilitated the placement, indicating strong institutional support. The conditional placement to directors, pending shareholder approval, adds an additional layer of governance and confidence.
Looking Ahead
As Titomic moves forward with its expansion, the market will be keen to see how effectively the company leverages this capital to enhance its technological leadership and commercial footprint. The upcoming shareholder meeting will be a key event to watch, particularly regarding approval of the conditional placement and any further strategic updates.
Bottom Line?
Titomic’s A$50 million raise sets the stage for accelerated growth, but execution risks remain as investors await tangible progress.
Questions in the middle?
- How will the capital raise impact shareholder dilution and earnings per share?
- What specific expansion projects or markets will the proceeds target first?
- Will the conditional placement to directors receive shareholder approval at the AGM?
